title: [Cold agglutinin disease of IgA class as early manifestation of multiple myeloma and resolution after treatment with new anti-myeloma drugs].
authors.affiliation: Servicio de Hematología, Instituto Maimónides de Investigación Biomédica de Córdoba IMIBIC/Hospital Universitario Reina Sofía, Córdoba, España. Electronic address: carolina.chic.acevedo@gmail.com.
authors.forename: Carolina
authors.initials: C
authors.lastname: Chic Acevedo
authors.affiliation: Servicio de Hematología, Instituto Maimónides de Investigación Biomédica de Córdoba IMIBIC/Hospital Universitario Reina Sofía, Córdoba, España.
authors.forename: Estefanía
authors.initials: E
authors.lastname: García Torres
authors.affiliation: Servicio de Hematología, Instituto Maimónides de Investigación Biomédica de Córdoba IMIBIC/Hospital Universitario Reina Sofía, Córdoba, España.
authors.forename: Miguel Ángel
authors.initials: MÁ
authors.lastname: Álvarez Rivas
mesh_terms: D000744:Anemia, Hemolytic, Autoimmune / Q000097:blood / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D003520:Cyclophosphamide / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood; D000077269:Lenalidomide; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D013792:Thalidomide / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D015415:Biomarkers; D007070:Immunoglobulin A; D013792:Thalidomide; D003907:Dexamethasone; D003520:Cyclophosphamide; D000077269:Lenalidomide